KIMBERLY FORD: Open Payments
NPI 1477160927 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 8 payments from 7 companies in 2025. Trend: 2023 $367 · 2024 $387 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $187 |
| Amgen Inc. | 1 | $122 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $115 |
| Atland Pharmaceuticals, LLC | 1 | $38 |
| Novo Nordisk Inc | 1 | $15 |
Products named: BREZTRI, Repatha, PENMENVY, REXULTI, Kerendia, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, Ozempic.
Industry payments across AL — which companies pay providers there.
